Citations

Mayo Clinic

Showing 10 of 108572 citations.

The Vascularized Medial Femoral Condyle (MFC) Flap for Non-Scaphoid Reconstruction in the Upper and Lower Extremities
Wan, Rou , Sarcon, Aida K. , Tunaboylu, Mehmet Furkan , Peña, Angélica , Aggarwal, Ananya , Moran, Steven L. , Pena, Angelica, Aggarwal, Ananya

Plastic and Reconstructive Surgery - Global Open | January 8, 2024 | Volume: 12 | Issue: 1S1 | Pages: 39-39

10.1097/01.gox.0001006056.61782.50 Get It

Life or Limb - Why Not Both? Pediatric Lower Extremity Reconstruction with Concomitant Gustilo Class 3 Fractures
Upadhyaya, Raghave M., Burns, Heather R. , Buchanan, Edward P. , Reece, Edward M., Perkins, Christopher, Pederson, William C., Xue, Amy S., Abu‐Ghname, Amjed , Perkins, Christopher M.

Plastic and Reconstructive Surgery - Global Open | January 8, 2024 | Volume: 12 | Issue: 1S1 | Pages: 21-21

10.1097/01.gox.0001005948.38773.b9 Get It

Criminality in patients with autoimmune encephalitis: A case series
Michael, Sophia , Varley, James , Williams, Robyn , Tomasz, Bajorek, Easton, Ava , Irani, Sarosh R. , Irani, Sarosh R , Williams, Robyn L

European Journal of Neurology | January 8, 2024 | Volume: 31 | Issue: 4 | Pages: No page available

10.1111/ene.16197 | PMID 38189625 Get It

AbstractBackground and purposeDespite it being an immunotherapy‐responsive neurological syndrome, patients with autoimmune encephalitis (AE) frequently exhibit residual neurobehavioural features. Here, we report criminal behaviours as a serious and novel postencephalitic association.MethodsThis retrospective cohort study included 301 AE patients. Five of who committed crimes underwent direct assessments and records review alongside autoantibody studies.ResultsFive of 301 patients (1.7%) with AE exhibited criminal behaviours, which included viewing child pornography (n = 3), repeated shoplifting, and conspiracy to commit murder. All five were adult males, with LGI1 autoantibodies (n = 3), CASPR2 autoantibodies, or seronegative AE. None had evidence of premorbid antisocial personality traits or psychiatric disorders. Criminal behaviours began a median of 18 months (range = 15 months–12 years) after encephalitis onset. At the time of crimes, two patients were immunotherapy‐naïve, three had been administered late immunotherapies (at 5 weeks–4 months), many neurobehavioural features persisted, and new obsessive behaviours had appeared. However, cognition, seizure, and disability measures had improved, alongside reduced autoantibody levels.ConclusionsCriminal behaviours are a rare, novel, and stigmatizing residual neurobehavioural phenotype in AE, with significant social and legal implications. With caution towards overattribution, we suggest they occur as part of a postencephalitis limbic neurobehavioural syndrome.
Stable thyroid cancer in a patient with thoracic aortic aneurysm and MYH11 variation
Fatourechi, Vahab , Swanson, Amy A. , Lee, Robert A.

Endocrinology, Diabetes & Metabolism Case Reports | January 8, 2024 | Volume: 2024 | Issue: 1 | Pages: No page available

10.1530/edm-23-0088 | PMID 38189791 Get It

Summary We report the case of a male patient with papillary thyroid cancer, familial thoracic aortic aneurysm and dissection, and a variation in the MYH11 gene. Because of considerable tumor bulk in the neck that was not resectable, the patient underwent partial resection at age 14 years. Since then, the patient has received only suppressive thyroid hormone therapy. He is now 71 years old, which is 57 years after the initial resection. The patient received care at our institution from July 2009 to August 2019, during which we documented the stability of multiple calcified masses in the neck. Follow-up examinations at another institution from September 2019 to April 2023 also confirmed the stability of the masses. The underlying cause of this unusually long indolent course of the disease is unclear. Whether extensive tumor calcifications or the MYH11 sequence variation contributed to the disease course is also uncertain. Learning points Papillary thyroid cancer with neck metastases may, in some cases, be stable and remain asymptomatic for decades. If locoregional stability of papillary thyroid cancer is documented for many years, observation may be preferable to extensive neck surgery in selected cases. This is the first report of an MYH11 gene alteration and thoracic aortic aneurysm in a patient with papillary thyroid cancer with indolent neck metastases. Future studies of MYH11 gene alterations in thyroid carcinoma are needed.
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma
Laoruangroj, Chonlada , Atherton, Pamela J. , Wiseman, Gregory A., Ansell, Stephen M. , Schumacher, Peyton, Witzig, Thomas E. , Witzig, T.E. , Feldman, Andrew L.

Leukemia & Lymphoma | January 8, 2024 | Volume: 65 | Issue: 3 | Pages: 333-338

10.1080/10428194.2023.2295792 | PMID 38189774 Get It

Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story
Goldsweig, Andrew M. , Deng, Yihong , Yao, Xiaoxi , Desai, Nihar R. , Cohen, David J. , Aronow, Herbert D. , Messé, Steven R. , Ross, Joseph S. , Lansky, Alexandra J. , Savitz, Samuel T. , Cohen, David Jonathan , Goldsweig, Andrew M , Yao, Xiaoxi , Ross, Joseph S , Aronow, Herbert D , Deng, Yihong

Circulation: Cardiovascular Quality and Outcomes | January 8, 2024 | Volume: 17 | Issue: 1 | Pages: No page available

10.1161/circoutcomes.123.010200 | PMID 38189127 Get It

BACKGROUND: Following regulatory approval, medical devices may be used “off-label.” Patent foramen ovale (PFO) closure is indicated to reduce recurrent stroke but has been proposed for other indications, including migraine, transient ischemic attack, and diving decompression illness. We sought to evaluate PFO closure rates and indications relative to the timing of regulatory approval and publication of key randomized trials. METHODS: We performed a retrospective cohort study using the OptumLabs Data Warehouse of US commercial insurance enrollees from 2006 to 2019. We quantified PFO closure among individuals with ≥2 years of preprocedure coverage to establish indications, classified hierarchically as stroke/systemic embolism, migraine, transient ischemia attack, or other. RESULTS: We identified 5315 patients undergoing PFO closure (51.8% female, 29.2%≥60 years old), which increased from 4.75 per 100 000 person-years in 2006 to 6.60 per 100 000 person-years in 2019. Patients aged ≥60 years accounted for 29.2% of closures. Procedure volumes corresponded weakly with supportive clinical publications and device approval. Among patients with PFO closure, 58.6% underwent closure for stroke/systemic embolism, 10.2% for transient ischemia attack, 8.8% for migraine, and 22.4% for other indications; 17.6% of patients had atrial fibrillation at baseline; and 11.9% developed atrial fibrillation postprocedure. Those aged ≥60 years and male were less likely to undergo closure for migraine than stroke/systemic embolism. CONCLUSIONS: From 2006 to 2019, PFO closure use was consistently low and corresponded weakly with clinical trial publications and regulatory status. Nearly half of patients underwent PFO closure for indications unapproved by the Food and Drug Administration. Regulators and payers should coordinate mechanisms to promote utilization for approved indications to ensure patient safety and should facilitate clinical trials for other possible indications.
Stretch response of the mechano-gated channel TMEM63A in membrane patches and single cells
Niloy, Sayeman Islam , Hannan, Elizabeth , Cowan, Luke M. , Linsenmeier, Fabian, Friedrich, Oliver , Farrugia, Gianrico , Beyder, Arthur , Strege, Peter R , Hannan, Elizabeth C, Cowan, Luke M , Farrugia, Gianrico , Beyder, Arthur , Strege, Peter R.

American Journal of Physiology-Cell Physiology | January 8, 2024 | Volume: 326 | Issue: 2 | Pages: C622-C631

10.1152/ajpcell.00583.2023 | PMID 38189136 Get It

TMEM63A has biophysical features distinctive for mechano-gated cation channels, but some properties are less clear, including no functional information in whole cells. We report that pressure-dependent yet voltage-independent TMEM63A currents in cell membrane patches correlated with cell size. In addition, radial stretch of whole cells on flexible membranes increased the [Ca2+]i responses more in TMEM63A-transfected cells. Inward TMEM63A currents in response to high stretch can depolarize plasma membranes and contribute to a sustained [Ca2+]i increase.
Frailty as a Predictor of Postoperative Morbidity and Mortality in Patients Aged 80 Years and Older Undergoing Instrumented Fusion
Moniz‐Garcia, Diogo , Odeh, Nour , Genel, Oktay , Sousa‐Pinto, Bernardo , Otamendi-Lopez, Andrea, Nottmeier, Eric W. , Bydon, Mohamad , McClendon, Jamal, Buchanan, Ian A. , Pirris, Stephen M. , Chen, Selby , Montaser, Alaa, Nottmeier, Eric, Pirris, Stephen , Garcia, Diogo Moniz , Montaser, Alaa S. , Biase, Gaetano De , Abode-Iyamah, Kingsley

Operative Neurosurgery | January 8, 2024 | Volume: 26 | Issue: 6 | Pages: 669-676

10.1227/ons.0000000000001040 | PMID 38189376 Get It

BACKGROUND AND OBJECTIVES: Degenerative spine disease is a leading cause of disability, with increasing prevalence in the older patients. While age has been identified as an independent predictor of outcomes, its predictive value is limited for similar older patients. Here, we aimed to determine the most predictive frailty score of adverse events in patients aged 80 and older undergoing instrumented lumbar fusion. METHODS: We proceeded with a multisite (3 tertiary academic centers) retrospective review including patients undergoing instrumented fusion aged 80 and older from January 2010 to present. A composite end point encompassing 30-day return to operating room, readmission, and mortality was created. We estimated the area under the receiver operating characteristic curve for frailty scores (Modified Frailty Index-5 [MFI-5], Modified Frailty Index-11 [MFI-11], and Charlson Comorbidity Index [CCI]) in relation to that composite score. In addition, we estimated the association between each score and the composite end point by means of logistic regression. RESULTS: A total of 153 patients with an average age of 85 years at the time of surgery were included. We observed a 30-day readmission rate of 11.1%, reoperation of 3.9%, and mortality of 0.6%. The overall rate of the composite end point at 30 days was 25 (15.1%). The AUC for MFI-5 was 0.597 (0.501-0.693), for MFI-11 was 0.620 (0.518-0.723), and for CCI was 0.564 (0.453-0.675). The association between the scores and composite end point did not reach statistical significance for MFI-5 (odds ratio [OR] = 1.45 [0.98-2.15], P = .061) and CCI (OR = 1.13 [0.97-1.31], P = .113) but was statistically significant for MFI-11 (OR = 1.46 [1.07-2.00], P = .018). CONCLUSION: This is the largest study comparing frailty index scores in octogenarians undergoing instrumented lumbar fusion. Our findings suggest that while MFI-11 score correlated with adverse events, the predictive ability of existing scores remains limited, highlighting the need for better approaches to identify select patients at age extremes.
Trends in the Utilization of Surgical Modalities for the Treatment of Drug-Resistant Epilepsy: A Comprehensive 10-Year Analysis Using the National Inpatient Sample
Ghaith, Abdul Karim , El-Hajj, Victor Gabriel , Sánchez-Garavito, Jesús E. , Zamanian, Cameron , Bon‐Nieves, Antonio , Drees, Cornelia , Miller, David A. , Parker, Jonathon J. , Elmi‐Terander, Adrian , Tatum, William O. , Middlebrooks, Erik H. , Bydon, Mohamad , Ghanem, Marc , Bon-Nieves, Antonio, Chen, Baibing , Drees, Cornelia N, Elmi-Terander, Adrian , Van Gompel, Jamie J , Lundstrom, Brian Nils , Grewal, Sanjeet , Middlebrooks, Erik H , Ghaith, Abdul Karim , El-Hajj, Victor Gabriel , Bon-Nieves, Antonio A , Drees, Cornelia , Almeida, João Paulo , Gompel, Jamie J. Van , Lundstrom, Brian N. , Grewal, Sanjeet S.

Neurosurgery | January 8, 2024 | Volume: 94 | Issue: 6 | Pages: 1191-1200

10.1227/neu.0000000000002811 | PMID 38189460 Get It

BACKGROUND AND OBJECTIVES: Epilepsy is considered one of the most prevalent and severe chronic neurological disorders worldwide. Our study aims to analyze the national trends in different treatment modalities for individuals with drug-resistant epilepsy and investigate the outcomes associated with these procedural trends in the United States. METHODS: Using the National Inpatient Sample database from 2010 to 2020, patients with drug-resistant focal epilepsy who underwent laser interstitial thermal therapy (LITT), open surgical resection, vagus nerve stimulation (VNS), or responsive neurostimulation (RNS) were identified. Trend analysis was performed using piecewise joinpoint regression. Propensity score matching was used to compare outcomes between 10 years prepandemic before 2020 and the first peak of the COVID-19 pandemic. RESULTS: This study analyzed a total of 33 969 patients with a diagnosis of drug-resistant epilepsy, with 3343 patients receiving surgical resection (78%), VNS (8.21%), RNS (8%), and LITT (6%). Between 2010 and 2020, there was an increase in the use of invasive electroencephalography monitoring for seizure zone localization ( P = .003). There was an increase in the use of LITT and RNS ( P < .001), while the use of surgical resection and VNS decreased over time ( P < .001). Most of these patients (89%) were treated during the pre-COVID pandemic era (2010-2019), while a minority (11%) underwent treatment during the COVID pandemic (2020). After propensity score matching, the rate of pulmonary complications, postprocedural hematoma formation, and mortality were slightly higher during the pandemic compared with the prepandemic period ( P = .045, P = .033, and P = .026, respectively). CONCLUSION: This study indicates a relative decrease in the use of surgical resections, as a treatment for drug-resistant focal epilepsy. By contrast, newer, minimally invasive surgical approaches including LITT and RNS showed gradual increases in usage.
Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma
Dhaliwal, Gurman , Shahin, Ahmad , Lim, Elisabeth S. , Mi, Lanyu , Mangold, Aaron R. , Swanson, David C. , Dhaliwal, Gurman S, Shahin, Ahmad B , Swanson, David L, Costello, Collin M , Mangold, A R , Costello, Collin M.

Cancer Medicine | January 8, 2024 | Volume: 13 | Issue: 1 | Pages: No page available

10.1002/cam4.6888 | PMID 38186321 Get It

AbstractBackgroundImmunotherapies have changed the landscape of late‐stage melanoma; however, data evaluating timely access to immunotherapy are lacking.MethodsA retrospective cohort study utilizing the National Cancer Database was conducted. Stage III and IV melanoma cases diagnosed between 2011 and 2018 that received systemic treatment with either immunotherapy or chemotherapy were included. Chemotherapy included BRAF/MEK inhibitors. Multivariable logistic regression models were utilized to evaluate factors associated with the likelihood of receiving immunotherapy as primary systemic treatment relative to chemotherapy; additionally, Cox proportional hazards models were utilized to incorporate time from diagnosis to primary systemic therapy into the analysis.ResultsThe study population was comprised of 14,446 cases. The cohort included 12,053 (83.4%) immunotherapy and 2393 (16.6%) chemotherapy cases. In multivariable logistic regression analysis, factors significantly associated with immunotherapy receipt included population density, circle distance, year of diagnosis, Breslow thickness, and cancer stage. Immunotherapy timing was evaluated using multivariable Cox regression analysis. Minorities were less likely to receive timely immunotherapy than non‐Hispanic Whites (HR 0.83, CI 0.74–0.93, p = 0.001). Patients at circle distances of 10–49 miles (HR 0.94, CI 0.89–0.99, p = 0.02) and ≥50 miles (HR 0.83, CI 0.77–0.90, p < 0.001) were less likely to receive timely immunotherapy.ConclusionPatients traveling ≥10 miles and minorities have a decreased likelihood of receiving timely immunotherapy administration for primary systemic treatment. Future research is needed to identify what barriers and approaches can be leveraged to address these inequities.